Article

Paxlovid for Treating Hospitalized COVID-19 Patients with Kidney Injury

2023-01-03

Abstract excerpt

Background: Coronavirus disease 2019 (COVID-19) causes significant mortality during the pandemic in recent years. Paxlovid, an HIV-1 protease and CYP3A inhibitor, reduces mortality and hospitalization rate in patients infected with the Omicron variant of SARS-CoV-2. However, data regarding the effectiveness of Paxlovid in treating COVID-19 patients with kidney injury are limited.<br><br>Methods: The clinical data...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 024e1b9f-21fe-5dc6-b295-d3b08c7c1e30
DOI: 10.2139/ssrn.4314013

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Paxlovid for Treating Hospitalized COVID-19 Patients with Kidney InjuryDOI 10.2139/ssrn.4314013Read

Comparative study of COVID-19 infection in renal transplant recipients and non transplant recipientsSemantic proximity Read

Are patients on chronic hemodialysis treatment protected against mortality due to COVID-19? A single-center retrospective cohort of patients hospitalized with COVID-19 requiring hemodialysis treatmentSemantic proximity Read

Clinical characteristics and outcomes in COVID-19 patients with chronic kidney disease in the SARS-CoV-2 Omicron wave: a case-control studySemantic proximity Read

Comparative Study of COVID-19 Infection in Renal Transplant Recipients and Non Transplant RecipientsSemantic proximity Read

Covid-19 in end-stage renal disease patients with renal replacement therapies: a systematic review and meta-analysisSemantic proximity Read

Comparative study of COVID-19 infection in renal transplant recipients and non transplant recipientsSemantic proximity Read

Kidney Allograft Recipients Diagnosed with Coronavirus Disease-2019: A Single Center ReportSemantic proximity Read

Use of an extended KDIGO definition to diagnose acute kidney injury in patients with COVID-19: A multinational study of the ISARIC cohortSemantic proximity Read

Coronavirus disease 2019 and kidney injury.Semantic proximity Read

COVID-19 Incidence and Mortality in Pre-Dialysis Chronic Kidney Disease PatientsSemantic proximity Read

Development and validation of the MMCD score to predict kidney replacement therapy in COVID-19 patientsSemantic proximity Read

Comparative effectiveness of Paxlovid versus sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in non-hospitalised patients: observational cohort study using the OpenSAFELY platformSemantic proximity Read